Jove
Visualize
Contact Us

Related Concept Videos

Drug Regulation01:25

Drug Regulation

2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
Drug Nomenclature01:17

Drug Nomenclature

2.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.8K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

147
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
147
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

297
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
297
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

86
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resilience in Urban Pharmacies: A Mixed-Methods Model for Performance and Patient Satisfaction During Crises.

Iranian journal of pharmaceutical research : IJPR·2026
Same author

Development and Assessment of a Decentralization Framework in Iran Pharmaceutical Regulatory Systems Based on Good Governance Indicators.

Iranian journal of pharmaceutical research : IJPR·2025
Same author

Developing a Discrete Choice Experiment Instrument for Evaluating Patients' Preferences in Precision Oncology.

Iranian journal of pharmaceutical research : IJPR·2025
Same author

Investigating the Relationship Between the Market Orientation Approach of Pharmaceutical Companies and Their Innovative Performance: The Mediating Role of Dynamic Capabilities and Corporate Social Responsibility.

Iranian journal of pharmaceutical research : IJPR·2025
Same author

Cost-effectiveness analysis of a community pharmacist-based intervention to prevent cardiovascular complications in patients with type 2 diabetes in Iran.

Cost effectiveness and resource allocation : C/E·2025
Same author

Examining the impact of emotional intelligence on job performance with the mediating role of clinical competence in nurses: a structural equation approach.

BMC nursing·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 9, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K

Attributes Development for Pharmaceutical Subsidization: A Qualitative Study.

Gita Afsharmanesh1, Gholamhossein Mehralian1, Farzad Peiravian1

  • 1Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Iranian Journal of Pharmaceutical Research : IJPR
|September 14, 2020
PubMed
Summary

This study identifies key attributes for health resource allocation preferences using qualitative methods. Findings inform discrete choice experiments (DCEs) for pharmaceutical subsidization decisions.

Keywords:
Attribute and attribute-levelDiscrete choice experimentPharmaceutical subsidizationQualitative research

More Related Videos

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
08:06

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

Published on: November 10, 2016

7.8K
Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

1.2K

Related Experiment Videos

Last Updated: Dec 9, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K
Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
08:06

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

Published on: November 10, 2016

7.8K
Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

1.2K

Area of Science:

  • Health Economics
  • Health Services Research
  • Decision Science

Background:

  • Discrete choice experiments (DCEs) are increasingly used to assess health preferences.
  • However, limited evidence exists on selecting appropriate attributes and attribute-levels for DCEs in health resource allocation.

Purpose of the Study:

  • To identify and develop relevant attributes and attribute-levels for eliciting public preferences in health resource allocation.
  • To provide methodological evidence for designing precise DCEs, particularly in low and middle-income countries.

Main Methods:

  • A qualitative study employing semi-structured interviews with 16 key informants and decision-makers.
  • Thematic analysis of transcribed interviews, followed by a focus group discussion with 7 experts.
  • Literature review to identify an initial list of attributes.

Main Results:

  • Initial interviews yielded 311 codes across four main dimensions.
  • Attributes were refined and limited to four manageable factors for DCEs: disease severity, health gain, patient frequency, and treatment cost.
  • This process provides evidence for attribute development in DCEs.

Conclusions:

  • This qualitative study successfully identified and refined attributes for DCEs on pharmaceutical subsidization.
  • The findings contribute empirical evidence to the methodological literature on attribute development for DCEs in health policy.
  • The study supports the design of precise DCEs to understand public preferences in resource allocation.